Brittany Bradrick
Directeur/Bestuurslid bij DERMATA THERAPEUTICS, INC.
Vermogen: 498 $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| David Hale | M | 75 |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 17 jaar |
| Gerry Proehl | M | 65 | 10 jaar | |
| Craig Charles Chambliss | M | - |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 17 jaar |
| James Hollingshead | M | 61 | 5 jaar | |
| Lauren Budden | F | 49 | 5 jaar | |
| Sean Proehl | M | - | 3 jaar | |
| Wendell Wierenga | M | 76 | 8 jaar | |
| Mary Fisher | F | 62 | 3 jaar | |
| Eric Benjamin | M | 41 | 6 jaar | |
| Steven Mento | M | 72 | 3 jaar | |
| John Kapples | M | 64 | 5 jaar | |
| Kathleen Scott | F | 55 | 3 jaar | |
| Andrew Sandler | M | 58 | 3 jaar | |
| Stephen H. Jenner | M | 56 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 5 jaar |
| Enrique Carrazana | M | 62 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 4 jaar |
| Michael Minogue | M | 57 | 7 jaar | |
| Kevin Kaijun Li | M | - |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | - |
| Christopher Nardo | M | 59 | 9 jaar | |
| Kyri van Hoose | M | - | 3 jaar | |
| Dan Manea | M | 57 | 4 jaar | |
| Angela Wiczek | F | - | 4 jaar | |
| Priyanka Belawat | M | 45 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | - |
| Trang Ly | M | - | 8 jaar | |
| Thomas Liquard | M | 51 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 7 jaar |
| David Smith | M | 64 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 3 jaar |
| Huai Zheng Peng | M | 62 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | - |
| Maria Bedoya-Toro Munera | M | 72 | 8 jaar | |
| Steve Cartt | M | 61 |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | 4 jaar |
| Mark Field | M | 53 | 5 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Thomas Riga | M | 48 | 10 jaar | |
| Patrick Sullivan | M | 72 | 5 jaar | |
| Wayde McMillan | M | 54 | 4 jaar | |
| Michael Yang | M | 62 |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | - |
| Michael Levitz | M | 50 | 4 jaar | |
| Daniel Levangie | M | 73 | 6 jaar | |
| Paul Laikind | M | 68 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 8 jaar |
| Jeffrey Vacirca | M | 55 | 5 jaar | |
| Dolatrai Vyas | M | 80 | 9 jaar | |
| Corinne Nevinny | F | 64 | 5 jaar | |
| William Ashton | M | 73 | 5 jaar | |
| Regina Sommer | F | 66 | 9 jaar | |
| Ju-Hyun Lim | F | 49 | 1 jaar | |
| Joseph Zakrzewski | M | 60 | 9 jaar | |
| James Mullen | M | 65 | 2 jaar | |
| David Colleran | M | 52 | 4 jaar | |
| Ethan Butler | M | - | 2 jaar | |
| Annette Matthies | M | 47 |
Abbott Laboratories, Inc.
 Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 1 jaar |
| Cheng Peiling | M | - | 1 jaar | |
| Jeffrey Kent | M | 62 |
Abbott Laboratories, Inc.
Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 8 jaar |
| Kathy V. Turner | F | 60 |
Abbott Laboratories, Inc.
Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 25 jaar |
| Bret Christensen | M | 53 | 6 jaar | |
| Shanta P. Chawla | M | 76 | - | |
| Aiman Abdel-Malek | M | 65 | 3 jaar | |
| Mark Licari | M | - | 2 jaar | |
| Christopher Gilbert | M | - | 5 jaar | |
| Frédéric Jacotot | M | 60 |
Abbott Laboratories, Inc.
Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 3 jaar |
| Francois Lebel | M | 72 | 4 jaar | |
| Brad Thomas | M | - | 4 jaar | |
| Kevin D'Amour | M | 51 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | - |
| Adam Koppel | M | 54 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 3 jaar |
| Seth Fischer | M | 68 | 3 jaar | |
| Timothy Kieffer | M | 58 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 1 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 62 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Brittany Bradrick
- Persoonlijk netwerk
